Treatment for Cellulitis
For typical cases of cellulitis without systemic signs of infection, a 5-day course of antibiotics active against streptococci is the recommended treatment. 1
Antimicrobial Selection Algorithm
Mild Cellulitis (No Systemic Signs)
- First-line treatment: Antibiotics active against streptococci 1
- Penicillin
- Amoxicillin
- Dicloxacillin
- Cephalexin (500 mg every 6 hours orally)
- Clindamycin (if penicillin allergic)
Moderate Cellulitis (With Systemic Signs)
- Treatment: Systemic antibiotics with consideration for MSSA coverage 1
- Cefazolin (0.5-1 g every 8 hours IV)
- Oxacillin/nafcillin (2 g every 6 hours IV)
Severe Cellulitis or High Risk for MRSA
- Treatment: Coverage for both MRSA and streptococci 1
- Vancomycin (15 mg/kg every 12 hours IV)
- Linezolid (600 mg every 12 hours)
- Daptomycin
- Telavancin
- Oral options: doxycycline, clindamycin, or SMX-TMP
Special Circumstances
- Severely compromised patients: Broad-spectrum coverage with vancomycin plus either piperacillin-tazobactam or imipenem/meropenem 1
Duration of Therapy
- Standard duration: 5 days 1
- Extend treatment if infection has not improved within 5 days 1
- Recent evidence confirms that 5-6 days of therapy is as effective as longer courses for uncomplicated cellulitis 1, 2
Adjunctive Measures
- Elevation of affected area to promote drainage of edema and inflammatory substances 1
- Treatment of predisposing factors such as edema, obesity, eczema, venous insufficiency, and toe web abnormalities 1
- Consider systemic corticosteroids (prednisone 40 mg daily for 7 days) in non-diabetic adult patients to hasten resolution 1, 3
- For recurrent cellulitis: Address underlying conditions and consider prophylactic antibiotics for patients with 3-4 episodes per year 1
Hospitalization Criteria
Hospitalize patients with:
- Systemic inflammatory response syndrome (SIRS)
- Altered mental status
- Hemodynamic instability
- Concern for deeper or necrotizing infection
- Poor adherence to therapy
- Severe immunocompromise
- Failure of outpatient treatment 1
Common Pitfalls and Caveats
Misdiagnosis: Cellulitis is often confused with conditions like venous stasis dermatitis, contact dermatitis, and lymphedema 4. Ensure proper diagnosis before initiating treatment.
MRSA coverage: MRSA is an unusual cause of typical cellulitis. Routine MRSA coverage is unnecessary for uncomplicated, non-purulent cellulitis 1, 4. Reserve MRSA coverage for specific risk factors:
- Penetrating trauma
- Evidence of MRSA infection elsewhere
- Nasal colonization with MRSA
- Injection drug use
- Purulent drainage
- SIRS 1
Cultures: Blood or skin cultures are not routinely recommended for typical cellulitis 1. Reserve cultures for:
- Patients with malignancy on chemotherapy
- Neutropenia
- Severe cell-mediated immunodeficiency
- Immersion injuries
- Animal bites 1
Interdigital spaces: In lower-extremity cellulitis, carefully examine interdigital toe spaces and treat any fissuring, scaling, or maceration to prevent recurrence 1
Recurrent cellulitis: For patients with recurrent episodes, identify and treat predisposing factors. Consider prophylactic antibiotics for those with 3-4 episodes per year 1
By following this evidence-based approach to cellulitis treatment, clinicians can effectively manage this common infection while minimizing unnecessary antibiotic use and preventing complications.